Treatment for Heart Failure Prevention More Effective in Females than Males
A study conducted by the scientists at the Boston Scientific and the University of Rochester Medical Center, says that women are more benefited from CRT-D (cardiac resynchronization therapy with defibrillator) than their male counterparts. Women noticed 70% decrease in heart failure and 72% reduced death rate after the treatment.
The study was conducted on 1,820 participants from about 110 medical centers in Canada, the US and the Europe. The researchers compared the efficacy of CRT-D against that of ICD therapy in the reduction of heart failure as well as the death. 453 participants of the study were females.
According to Arthur J. Moss, M.D.,the lead author of the study, this treatment greatly benefits the women. The reduction in the heart failures in women was 70% whereas, in men it was 35% (twice less in women than in men). Women usually have non-ischemic heart disease and left bundle branch block which are more responsive to the CRT-D therapy. The therapy strengthens the complete pumping action of the heart and also coordinates the electrical activity of the heart. The study is published in the Journal of the American College of Cardiology.